GLP-1 drugsReview

Cardiovascular protection beyond glucose lowering: GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonism in contemporary cardiology

Figure 1. Evidence-graded mechanistic framework for cardiovascular effects of GLP-1-based therapies.
Open the figure at full size
Figure 1. Evidence-graded mechanistic framework for cardiovascular effects of GLP-1-based therapies.Evidence-graded mechanistic framework for cardiovascular effects of GLP-1-based therapies.Li

Frontiers in Cardiovascular Medicine

The paper

Siping City Central People’s Hospital

Frontiers in Cardiovascular Medicine · 16 Sep 2026

doi.org/10.3389/fcvm.2026.1926629PubMed 42819943

More on GLP-1 receptor agonists